Ladder Bio
ladderbio.com
Actively hiring
Professional Services
Biotechnology
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
We have developed a novel chemical platform of synthetic, modular, fused-ring structures with a diverse range of functional groups, allowing us exquisite.
News
Ladder Bio Appoints Jay Fine, PhD and John Prufeta to Board of Directors
Two appointments add drug development and defense-sector expertise to Ladder Bio's Board as the company advances its Spiroligomer platform
Read more
Report
ThirdLaw Molecular Rebrands as Ladder Bio; Announces $5.5M Seed Financing Led by Medical Excellence Capital and Appoints Eric Heil as Chief Executive Officer
Philadelphia, PA - November 12, 2025 - ThirdLaw Molecular, Inc. today announced its new name change, Ladder Bio Inc., reflecting the company's mission to
Read more
Report
ThirdLaw Molecular's Senior Biologist to Present at SLASEurope 2025 as Part of Elite Innovation AveNEW Selection
Media Contact:Alison [email protected]
Read more
Report
ThirdLaw Molecular Inc. Launches its Groundbreaking Platform for Targeted Drug Discovery with a 4.5-Billion Molecule DNA-Encoded Library of Spiroligomer Macromolecules
Media Contact:
Read more
Report
Dr. Joseph Vacca Joins Dr. Tomi Sawyer as Scientific Advisor to ThirdLaw Molecular
Award winning medicinal chemist, Dr. Joseph Vacca, joins Third Law Molecular LLC as Scientific Advisor, bringing deep drug discovery and development
Read more
Report